4//SEC Filing
Doyle John Brendan 4
Accession 0001062993-25-013357
CIK 0001455365other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 4:23 PM ET
Size
6.6 KB
Accession
0001062993-25-013357
Insider Transaction Report
Form 4
Doyle John Brendan
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-07-29$0.67/sh−9,360$6,273→ 425,350 total - Award
Common Stock
2025-07-29+30,000→ 434,710 total
Footnotes (2)
- [F1]Shares earned upon the vesting of performance stock units ("PSUs") granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. 50% of the total number of shares subject to the PSUs vested on July 29, 2025.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.
Issuer
COGNITION THERAPEUTICS INC
CIK 0001455365
Entity typeother
Related Parties
1- filerCIK 0001840738
Filing Metadata
- Form type
- 4
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 4:23 PM ET
- Size
- 6.6 KB